|
Presentations on the HPTN Domestic Research Agenda
to the DAIDS Strategic Working Group are now available.
View Presentations from the 2008 HPTN PrEP
Consultative Meeting.
Read
"Responding to an Evolving US Epidemic: An HIV Prevention Research
Agenda" from the HPTN Domestic Prevention Working Group.
Presentations from the HPTN Annual Meeting are now
available online.
|
|
Welcome
to the HPTN Web site
What
is the HPTN?
The HIV Prevention Trials Network
(HPTN) is a worldwide collaborative clinical trials network that develops and
tests the safety and efficacy of primarily non-vaccine interventions designed to prevent the transmission of HIV. Established
in 1999 and refunded in 2006 by the Division of AIDS
(DAIDS)
of the National Institute of Allergy and
Infectious Diseases (NIAID), part of the National Institutes of Health
(NIH), the HPTN carries out its mission through a strong network of expert
scientists and investigators from more than two dozen international sites partnered
with a leadership group comprised of three U.S.-based institutions.
The strengths of the HPTN
include:
|
 |
Leadership by experts in the
prevention sciences |
|
|
Coordinated
domestic-international research agenda |
|
|
Multi-disciplinary study
teams of behavioral, clinical, epidemiological, laboratory, operations, and
statistical researchers |
|
|
Capability to conduct
cross-cultural comparisons among different host and viral populations |
|
|
Emphasis on
community involvement in all aspects of the research process, from trial
development through implementation |
|
|
Emphasis on ethical
guidelines in research |
|
|
